Description

// WHAT_IS_DSIP

DSIP (Delta Sleep-Inducing Peptide) is a 9-amino-acid neuropeptide first isolated from rabbit thalamic venous blood in 1977. It has been studied across sleep architecture, stress response, and neuroendocrine modulation models.

// RESEARCH_PATHWAYS

DSIP research across several decades has mapped three principal research domains:

• Sleep Architecture: Promotes slow-wave (delta) sleep in animal studies — research interest in sleep stage modulation without sedation profiles of conventional compounds
• HPA Axis Modulation: Modulates corticotropin and ACTH release in animal models — stress response axis research
• Neuroendocrine Signaling: Interacts with LH, somatostatin, and GH release pathways in preclinical models

// RESEARCH_AREAS

• Sleep stage and delta wave induction studies
• HPA axis and stress response research
• Neuroendocrine modulation models
• Antioxidant and neuroprotective investigations
• Circadian rhythm research models

// COMMON_PROTOCOLS

Research protocols and administration parameters are being compiled for our full product brief — coming soon. Third-party CoA and purity certificate will accompany the full brief.

// THE_EVIDENCE_PICTURE

DSIP has a decades-long preclinical evidence base and some early human research (1970s-1990s literature). Contemporary replication data is limited — the evidence picture is mixed and being reassessed in modern research contexts.

// DISCLAIMER

Research use only. Not FDA approved. Not for human consumption. Educational content only — anecdote does not equal evidence.